Tenax Therapeutics, Inc. (TENX) Financials
TENX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 11.9 million | 602214 |
2023-06-30 | 14.0 million | 823841 |
2023-03-31 | 15.3 million | 993861 |
2022-12-31 | 3.4 million | 1.9 million |
TENX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.1 million | ? |
2023-06-30 | -922966 | 50 |
2023-03-31 | -1.7 million | 66 |
2022-12-31 | -2.3 million | 85 |
TENX Net Income
No data available :(
TENX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 11.1 million | - | - |
2023-06-30 | 13.4 million | - | - |
2023-03-31 | 14.4 million | - | - |
2022-12-31 | 2.1 million | - | 183589 |
TENX Shares Outstanding
TENX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.1 million | 1.1 million | - |
2023-06-30 | - | 197903 | 1.0 million | - |
2023-03-31 | 1241 | 265735 | 1.3 million | - |
2022-12-31 | 2323 | 1.1 million | 1.4 million | - |
TENX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1000 |
2023-06-30 | - | 1000 |
2023-03-31 | - | 895 |
2022-12-31 | - | 29202 |
TENX
Price: $3.53
52 week price:
Earnings Per Share: -31.04 USD
P/E Ratio: -0.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 57000
Ebitda: -44.8 millionMarket Capitalization: 7.5 million